Erythrocyte G protein as a novel target for malarial chemotherapy
about
New Concepts in Malaria Pathogenesis: The Role of the Renin-Angiotensin SystemMalaria and human red blood cellsAn erythrocyte vesicle protein exported by the malaria parasite promotes tubovesicular lipid import from the host cell surfaceFurther evidence supporting a role for gs signal transduction in severe malaria pathogenesisA Putative Non-Canonical Ras-Like GTPase from P. falciparum: Chemical Properties and Characterization of the ProteinInhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates ParasitemiaImpairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides.Malaria, erythrocytic infection, and anemia.Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.In vitro genetic analysis of an erythrocyte determinant of malaria infection.Regulation of extracellular ATP in human erythrocytes infected with Plasmodium falciparumAntiparasitic chemotherapy: from genomes to mechanisms.The survival strategies of malaria parasite in the red blood cell and host cell polymorphisms.Cytoplasmic remodeling of erythrocyte raft lipids during infection by the human malaria parasite Plasmodium falciparumFunctional analysis of erythrocyte determinants of Plasmodium infectionApicomplexan parasites co-opt host calpains to facilitate their escape from infected cells.Effect of Propranolol Alone and in Combination with Pyrimethamine on Acute Murine Toxoplasmosis.Candidate human genetic polymorphisms and severe malaria in a Tanzanian population.Identification of the components of a glycolytic enzyme metabolon on the human red blood cell membrane.Host AMPK Is a Modulator of Plasmodium Liver InfectionDiverse evolutionary histories for beta-adrenoreceptor genes in humansRecent highlights in antimalarial drug resistance and chemotherapy research.CRIMALDDI: platform technologies and novel anti-malarial drug targets.Evaluation of Propranolol Effect on Experimental Acute and Chronic Toxoplasmosis Using Quantitative PCR.Cytoskeletal and membrane remodelling during malaria parasite invasion of the human erythrocyte.Gametocytogenesis in malaria parasite: commitment, development and regulation.Novel antimalarial drug targets: hope for new antimalarial drugs.The isoprenoid-precursor dependence of Plasmodium spp.Multispectral imaging: a review of its technical aspects and applications in anatomic pathology.Adverse neuropsychiatric effects of antimalarial drugs.Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens.The Plasmodium falciparum exported protein PF3D7_0402000 binds to erythrocyte ankyrin and band 4.1.Synthesis of 2-amino-3-arylpropan-1-ols and 1-(2,3-diaminopropyl)-1,2,3-triazoles and evaluation of their antimalarial activity.Temporal evaluation of commitment to sexual development in Plasmodium falciparum.PAK in pathogen-host interactions.Magnaporthe grisea cutinase2 mediates appressorium differentiation and host penetration and is required for full virulence.
P2860
Q26771362-AD0AF64D-4B79-4586-AA4C-9ED25922CBB9Q26829795-A4CB9F86-4520-40ED-87B1-C68B082E9EDEQ28473292-E2AC571B-077B-484B-AC48-0EF3CEA13B6BQ28473594-E2E22F07-47F3-4A7E-BD0D-D77B1C630A46Q28550705-507B40C5-A435-426A-B50A-7E6E7C7FD0EEQ28552868-12AB6953-2BDE-4CDB-8DED-AEE500DD4DD6Q33833640-655C1040-08C4-45F5-B7A1-3A496CF68821Q34103054-1D970443-B4EA-4985-B632-A4988343BF42Q34837191-08F89ED8-8F9A-41ED-B2AA-1527DCDBF0DBQ35022782-7A6DB903-C0C3-471E-BE31-0396B20F95CBQ35173532-E7930824-D80D-44A5-B255-6A34935F88F1Q35238319-BD01C958-11F5-4461-89D4-2BBD17813DEEQ35751882-E2952BF9-58A8-4268-BE11-2C5A4C8E410EQ35990740-4E277DA3-1A66-4BB8-8399-4183310C9CB4Q36059825-72B6ACF6-1CF0-4967-BFCA-139B25CA612CQ36081539-4A55A357-D81F-4477-BEFD-8D81F5B3CAC1Q36172056-D8FFA203-7AF2-43EA-8236-D84081805636Q36353877-D5DB5CF8-451F-40E0-8C92-B7A0837FFA46Q36526367-7E1AAEF3-6C38-4100-9269-F5F5357FE019Q37239234-163F2CD4-8D34-4CB9-90A9-B6032C133A8AQ37253431-50A9532E-6663-4B79-9027-261AACEA0CA5Q37283037-5E419998-7651-4C44-8721-48D9A8883A4AQ37308061-26058E49-A52D-43EB-92CE-FCA689787F6BQ37428612-4C9C99DF-22A0-4059-A9B4-510F893709E7Q37896123-3BB80255-A056-44DC-AA9C-49B4DB98FF81Q37955953-F941EFD3-55D5-451B-9D27-6390AAD4D10BQ37960187-8D19589E-DB94-4316-9DE3-C45B73A46E19Q38007363-C4EA5DD8-2174-4524-B83A-175B9EA7C753Q38152999-E9F96108-54B3-457F-9035-2F0F26AAC1FEQ38808162-01617899-780F-4BB3-B818-B4A19E4DDAC7Q39254514-B9134ED4-A351-4763-A8DB-B2EBC404C670Q40167577-0E94FF10-38F7-4CE1-A008-0AF13918F8F6Q40214778-3BBC138A-B369-4E35-8CF3-6C865018460CQ40861029-C7F5720D-2D20-4B24-820A-70F8640E5E38Q41592775-BB78EFC4-04D7-458D-B914-5BDE2052FE42Q48078148-F0B570A1-A1E6-453B-B2C5-2BBBA4D3400B
P2860
Erythrocyte G protein as a novel target for malarial chemotherapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Erythrocyte G protein as a novel target for malarial chemotherapy
@ast
Erythrocyte G protein as a novel target for malarial chemotherapy
@en
Erythrocyte G protein as a novel target for malarial chemotherapy
@en-gb
Erythrocyte G protein as a novel target for malarial chemotherapy
@nl
type
label
Erythrocyte G protein as a novel target for malarial chemotherapy
@ast
Erythrocyte G protein as a novel target for malarial chemotherapy
@en
Erythrocyte G protein as a novel target for malarial chemotherapy
@en-gb
Erythrocyte G protein as a novel target for malarial chemotherapy
@nl
altLabel
Erythrocyte G Protein as a Novel Target for Malarial Chemotherapy
@en
prefLabel
Erythrocyte G protein as a novel target for malarial chemotherapy
@ast
Erythrocyte G protein as a novel target for malarial chemotherapy
@en
Erythrocyte G protein as a novel target for malarial chemotherapy
@en-gb
Erythrocyte G protein as a novel target for malarial chemotherapy
@nl
P2093
P2860
P3181
P1433
P1476
Erythrocyte G protein as a novel target for malarial chemotherapy
@en
P2093
Heidi E Hamm
Jon W Lomasney
Kasturi Haldar
Sean C Murphy
Travis Harrison
P2860
P3181
P356
10.1371/JOURNAL.PMED.0030528
P407
P577
2006-12-01T00:00:00Z